Effects of apomorphine on locomotive activity and monoamine metabolism: A dose related study

Pakistan Journal of Pharmaceutical Sciences

Volumn 24, Issue 3, 2011, Pages 315-321

  Ikram, Huma ^a   Ahmad, Shoaib ^b   Haleem, Darakhshan Jabeen ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b FEDERAL URDU UNIVERSITY OF ARTS   (Pakistan)

Author keywords

Apomorphine; Behavioral sensitization; CNS stimulant; Dopamine; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; APOMORPHINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; SEROTONIN;

ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOME ENVIRONMENT; LOCOMOTION; MONOAMINE METABOLISM; MOTOR ACTIVITY; NONHUMAN; PARKINSON DISEASE; RAT; WITHDRAWAL SYNDROME;

ANIMALS; APOMORPHINE; BIOGENIC MONOAMINES; BRAIN; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MOTOR ACTIVITY; RATS; RATS, WISTAR;

EID: 79959950848     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Anderson SM, Schmidt HD and Pierce RC (2006). Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking. Neuropsychopharmacol., 31(7): 1452-1461.
2. Ansah TA, Wade LH and Shockley DC (1996). Changes in locomotor activity, core temperature and heart rate in response to repeated cocaine administration. Physiol. Behav., 60: 1261-1267. (Pubitemid 26389057)
3. Bloise E, Carey RJ and Carrera MP (2007). Behavioral sensitization produced by a single admiistration of apomorphine; Implications for the role of Pavlovian conditioning in the mediation of context-specific sensitization. Pharmacol. Biochem. Behav., 86: 449-457. (Pubitemid 46466876)
4. Boyce-Rustay JM, Wiedholz LM, Millstein RA, Carroll J, Murphy DL, Daws LC and Holmes A (2006). Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol Clin. Exp. Res., 30(12): 1957-1965. (Pubitemid 44749521)
5. Braga PQ, Galvanho JP, Bloise E, Carey JR and Carrera MP (2009). The expression of locomotor sensitization to apomorphine is dependent on time interval between injection and testing. Pharmacol. Biochem. Behav., 91(3): 278-282.
6. Bratcher NA, Farmer-Dougan V, Dougan JD, Heidenreich BA and Garris PA (2005). The role of dopamine in reinforcement: Changes in reinforcement sensitivity induced by D1-type, D2-type, and nonselective dopamine receptor agonists. J. Exp. Anal. Behav., 84(3): 371-399. (Pubitemid 43348207)
7. De La Garza RD and Cunningham KA (2000). The effects of the 5-hydroxytryptamine (1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J. Pharmacol. Exp. Ther., 292: 610-617.
8. Espejo EF, Serrano MI, Caillé S and Stinu L (2001). Behavioral Expression of Opiate Withdrawal is Altered after Prefrontocortical Dopamine Depletion in Rats: Monoaminergic Correlates. Neuropsychopharmacol., 25(2): 204-212. (Pubitemid 32566342)
9. Hagell P and Odin P (2001). Apomorphine in the treatment of Parkinson's disease. J. Neurosci. Nurs., 33(1): 21-38.
10. Haleem DJ, Batool F, Khan NH, Kamil N, Ali O, Saify ZS and Haleem MA (2002). Differences in the effects of haloperidol and clozapine on brain serotonin metabolism and o tests related to extrapyramidal functions in rats. Med. Sci. Monit., 8: 354-361.
11. Haleem DJ, Hasnat A, Shireen E, Khan A and Haleem MA (2005). Dopamine and serotonin neurotransmission in the reinforcing effects of alcohol and apomorphine. J. Coll. Physicians Surg. Pak., 15(8): 458-462. (Pubitemid 41288606)
12. Hasnat A and Haleem DJ (2005). Apomorphine-induced motor Sensitization and Reinforcement-Relationship with Dopamine and Serotonin. J. Bas. Appl. Sci., 1(2): 81-87.
13. Ikram H and Haleem DJ (2010). Haloperidol-induced Tardive Dyskinesia: Role of 5HT2C Receptors. Pak. J. Sci. Ind. Res., 53(3): 136-145.
14. Ikram H, Haleem DJ (2011). Attenuation of apomorphine-induced sensitization by buspirone, Pharmacol. Biochem. Behav., In press doi:10.1016/j.pbb.2011.04.007.
15. Ikram H, Samad N and Haleem DJ (2007). Neurochemical and Behavioral Effects of m-CPP in a Rat Model of Tardive Dyskinesia. Pak. J. Pharm. Sci., 20(3): 188-195.
16. Kiyatkin EA, Kiyatkin DE and Rebec GV (2000). Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats. Neuroscience, 98(4): 729-741. (Pubitemid 30417589)
17. Kuczenski R and Segal DS (1999). Sensitization of amphetamine-induced stereotyped behaviors during the acute response. J. Pharmacol. Exp. Ther., 288: 699-709.
18. Lyness WH, Friedle NM and Moore KE (1979). Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration. Pharmacol. Biochem. Behav., 11(5): 553-556. (Pubitemid 10143761)
19. Ma Y-Y, Guo C-Y, Yu P, Lee DY-W, Han J-S and Cui CL (2006). The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats. Exp. Neurol., 200(2): 343-355. (Pubitemid 44131532)
20. Mattingly BA, Caudill A and Abel M (2001). Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine. Pharmacol. Biochem. Behav., 68(3): 417-426. (Pubitemid 32452396)
21. Mattingly BA, Caudill A and Abel M (2001). Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine. Pharmacol. Biochem. Behav., 68(3): 417-426. (Pubitemid 32452396)
22. Muller CP, Carey RJ, Huston JP and De Souza Silva MA (2007). Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors. Prog. Neurobiol., 81: 133-178. (Pubitemid 46282275)
23. Nader MA and Czoty PW (2005). PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am. J. Psychiatry., 162(8): 1473-1482.
24. Neumaier JF, Vincow ES, Arvanitogiannis A, Wise RA and Carlezon WA Jr (2002). Elevated expression of 5- HT1B receptors in nucleus accumbens efferents sensitizes animals to cocaine. J. Neurosci., 22: 10856-10863. (Pubitemid 36005160)
25. Panlilio LV, Yasar S, Nemeth-Coslett R, Katz JL, Henningfield JE, Solinas M, Heishman SJ, Schindler CW and Goldberg SR (2005). Human cocaine-seeking behavior and its control by drug-associated stimuli in the laboratory. Neuropsychopharmacology, 30: 433-443. (Pubitemid 40129495)
26. Peters H, Yang H and Michael AC (2000). Quantitative aspects of brain microdialysis. Anal. Chim. Acta., 412: 1-12. (Pubitemid 30173255)
27. Pierce RC and Kumaresan V (2006). The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci. Biobehav. Rev., 30(2): 215-238. (Pubitemid 41821810)
28. Post RM and Rose H (1976). Increasing effects of repetitive cocaine administrationin the rat. Nature, 260: 731-732.
29. Przegalinski E, Siwanowicz J, Baran L and Filip M (2000). Activation of serotonin (5-HT)(1A) receptors inhibits amphetamine sensitization in mice. Life Sci., 66: 1011-1019. (Pubitemid 30090391)
30. Puech AJ, Simon P and Boissier J-R (1976). Antagonism by sulpiride of three apomorphine-induced effects in rodents. Eur. J. Pharmacol., 6(2): 439-441.
31. Ritz MC, Lamb RJ, Goldberg SR and Kuhar MJ (1998). Cocaine self-administration appears to be mediated by dopamine uptake inhibition. Prog. Neuropsychopharmacol. Biol. Psychiatr., 12(2-3): 233-239.
32. Sam E, Jeanjean AP, Maloteaux JM and Verbeke N (1995). Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application. Eur. J. Drug Metab. Pharmacokinet., 20(1): 27-33.
33. Shim I, Javaid JI, Wirtshafter D, Jang S-Y, Shin K-H, Lee H-J, Chung YC and Chun B-G (2001). Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat. Behav. Brain Res., 121(1-2): 137-147. (Pubitemid 32220141)
34. Symes AL, Lal S and Soukes TL (1976). Time-course of apomorphine in the brain of the immature rat after apomorphine injection. Arch. Int. Pharmacodyn. Ther., 223(2): 260-264.
35. Vetulani J (2001). Drug addiction-Part II: Neurobiology of addiction. Pol. J. Pharmacol., 53(4): 303-317.
36. Volkow ND, Fowler JS and Wang GJ (2003). The addicted human brain: Insights for imaging studies. J. Clin. Inves., 111: 1444-1451. (Pubitemid 38063274)
37. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009). Imaging dopamine's role in drug abuse and addiction. Neuropharmacology, 56(1): 3-8.
38. Wang WF, Lei YP, Tsenq T, Hsu WY, Wang CF, Hsu CC and Ho YJ (2007). Effects of apomorphine on the expression of learned helplessness behavior. Chin. J. Physiol., 50: 63-68.
39. Zijlstra F, Booij J, Van den Brink W and Franken IHA (2008). Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. Eur. Neuropsychopharmacol., 18(4): 262-270.